Publications

2003

Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J Biol Chem. 2003;278(45):44608-16.
Moscat J, Diaz-Meco MT. Par-4 keeps the atypical PKCs at bay. Cell Cycle. 2003;2(2):71-2.
Barbareschi M, Togni R, Aldovini D, Peterlini G, Dal Santo M, Sagramoso C, et al. [Tissue microarrays in oncology]. Pathologica. 2003;95(5):265-6.
Li Y, Yu W-, Ren J, Chen W, Huang L, Kharbanda S, et al. Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein. Mol Cancer Res. 2003;1(10):765-75.
Abécassis V, Jaffrelo L, Rickman D, Aggerbeck L, Herbert C, Truan G, et al. Microarray-based method for combinatorial library sequence mapping and characterization. Biotechniques. 2003;34(6):1272-9.
Harigopal M, Hoda SA, Seshan SV. Images in pathology: congo-red negative fibrillary glomerulonephritis. Int J Surg Pathol. 2003;11(4):313.
Cong F, Zhang J, Pao W, Zhou P, Varmus H. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. BMC Mol Biol. 2003;4:10.
Chilosi M, Zamò A, Brighenti A, Malpeli G, Montagna L, Piccoli P, et al. Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours. Virchows Arch. 2003;443(2):175-83.
Watnick RS, Cheng Y-, Rangarajan A, Ince TA, Weinberg RA. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell. 2003;3(3):219-31.
Crowson AN, Magro CM. Atrophying tinea versicolor: a clinical and histological study of 12 patients. Int J Dermatol. 2003;42(12):928-32.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700